Hannover Rueck SE stock analysis
Hannover Rueck SE (HNRB) Stock Price & Analysis
HNRB Stock Chart & Stats
- Day’s Range
- EUR 48.00 - EUR 49.00
- 52-Week Range
- EUR 36.80 - EUR 50.50
- Previous Close
- EUR 49.00
- Volume
- N/A
- Average Volume (3M)
- 0
- Market Cap
- EUR 35.52B
- Enterprise Value
- EUR 40.48B
- Total Cash (Recent Filing)
- EUR 60.89B
- Total Debt (Recent Filing)
- EUR 4.22B
- Price to Earnings (P/E)
- 3.9
- Beta
- 0.38
- Next Earnings
- Mar 11, 2027 (Est.)
- EPS Estimate
- 0.97
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 4.26%
Bulls Say, Bears Say
Bulls Say
Strong P&C Underwriting Profitability
A combined ratio well below target indicates that premium pricing and risk selection are currently generating substantial underwriting profit. This supports durable earnings quality, strengthens reserve resilience, and provides a solid operating base even if catastrophe activity or market conditions normalize.
Diversified Growth Across Reinsurance Businesses
Growth across both P&C and Life & Health reduces reliance on one business line and supports broader earnings resilience. Continued demand for diversified protection and financial solutions can sustain premium expansion while allowing Hannover Re to deploy capital across multiple reinsurance markets.
Strong Capitalization And Balance-Sheet Resilience
A 242% solvency ratio and rising equity provide substantial capacity to absorb insured losses, meet regulatory requirements, and support future underwriting opportunities. This financial strength enhances cedant confidence and gives management flexibility across changing reinsurance cycles.
Bears Say
P&C Competition And Rate Pressure
Falling rates and lower new business CSM indicate that competition is pressuring the economics of new P&C business. If capacity remains abundant, Hannover Re may face lower pricing power, slower growth in profitable contracts, and pressure on future underwriting margins.
Rising Capital Requirements
Higher capital requirements consume part of the benefit from operating capital generation and can constrain returns on equity. Continued increases would require more capital to support the same underwriting volume, reducing flexibility for growth, distributions, or adverse-loss absorption.
Weaker Recent Free-Cash-Flow Conversion
The recent decline in free cash flow and conversion versus net income weakens the quality and flexibility of reported earnings. Persistently lower cash generation could limit internally funded investment, capital returns, and the company’s ability to absorb claims or market-related cash needs.
Hannover Rueck SE News
HNRB FAQ
What was Hannover Rueck SE’s price range in the past 12 months?
What is Hannover Rueck SE’s market cap?
When is Hannover Rueck SE’s upcoming earnings report date?
How were Hannover Rueck SE’s earnings last quarter?
Is Hannover Rueck SE overvalued?
Does Hannover Rueck SE pay dividends?
What is Hannover Rueck SE’s EPS estimate?
How many shares outstanding does Hannover Rueck SE have?
What happened to Hannover Rueck SE’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Hannover Rueck SE?
What is the TipRanks Smart Score and how is it calculated?
Hannover Rueck SE Stock Smart Score
Company Description
Hannover Rueck SE
Hannover Rück SE, through its network of global subsidiaries, functions as a prominent international supplier of extensive reinsurance solutions and related services. Its business operations are primarily divided into two main areas: Property & Casualty Reinsurance and Life & Health Reinsurance. Within the Property & Casualty division, the company delivers a wide array of offerings. These include general property and casualty coverage, bespoke facultative reinsurance, protection against major catastrophic events (known as catastrophe XL), intricate structured reinsurance programs, and innovative insurance-linked securities. Moreover, it devises specialized risk management strategies for specific industries such as agriculture, livestock, and bloodstock; aviation and space endeavors; marine and offshore energy ventures; and complex exposures like credit, surety, and political risks. In the Life & Health sector, Hannover Rück provides reinsurance for various products, including group and individual credit life policies, enhanced annuity options, group life and health plans, and Takaful (Islamic insurance) products. It further extends its expertise to risk solutions concerning critical illness, disability, general health, longevity, long-term care, mortality, and morbidity. Beyond its core reinsurance activities, the firm also offers a suite of financial solutions. These encompass funding for new business initiatives, unlocking embedded value, providing crucial reserve and solvency relief, and facilitating the divestiture of non-essential business segments. Established in 1966 and based in Hanover, Germany, the company adopted its current name, Hannover Rück SE, in March 2013, having previously been known as Hannover Rückversicherung AG. It operates as a subsidiary of Talanx AG.
- Sector
- Financial
- Industry
- Insurance - Reinsurance
- CEO
- Clemens Jungsthofel
- Employees
- 4,078
- Website
- www.hannover-re.com
- Address
- Karl-Wiechert-Allee 50, Hanover, NI, 30625, DE
Hannover Rueck SE (HNRB) Earnings & Revenues
HNRB Company Deck
HNRB Earnings Call
Earnings Call SentimentPositive
The call was strongly constructive. Hannover Re reported robust profitability, a low P&C combined ratio, strong investment returns, excellent capitalization, positive Life & Health performance, and progress toward its full-year targets. The main challenges were intensified P&C competition, a EUR 300 million year-on-year decline in P&C new business CSM, higher capital requirements, assumption-related Life & Health impacts, currency losses, and higher unrealized fixed-income losses. Overall, the positive operating and financial trends significantly outweighed the stated challenges.
View all DE:HNRB earnings summariesTechnical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 15 | 5 | 2 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 12 | 0 | 0 |
